Who we help
Different questions, the same registers
A generics planner, an originator, a buyer, a parallel trader, a patent attorney and a consultant ask different questions of the same patents, licences and prices. Each page below is written for one of them: the questions they face, how MPA helps, and what to read first.
- Generics and biosimilar companiesWhen a molecule opens up in each market, what still stands in the way, and how big the opportunity is.How MPA helps
- Originators, brand and portfolio teamsYour exclusivity position and your competitors’, across Europe, kept current.How MPA helps
- Procurement and buyersWhich medicines are about to lose exclusivity, when prices move, and where supply is tightening.How MPA helps
- Parallel traders and wholesalersLicences, protection and prices in source and destination markets before you commit to stock.How MPA helps
- Patent attorneys and legal teamsAuthorisations, holders and dates checked against the official records, in 32 countries at once.How MPA helps
- Consultancies and advisersExclusivity, licensing and price facts for a due diligence, a market entry study or a portfolio review, checked at source.How MPA helps
- Not sure which page is yours?Tell us what you do and we will show you the parts of MPA Search that matter for it.Book a free demonstration
Clients
What clients say
“Having used MPA over many years it has formed a key part of our business planning process. The data provided allows my team to make product identification clearly targeted.”
“An invaluable component of our marketing and corporate decision-making strategic planning processes.”
“We have always found the service offered to be helpful and efficient.”